GSK, after pushing past midphase fail, ends development of otilimab in COVID-19

[anonymous]

unfortunately another R&D failure for GSK.

 

[anonymous]

It’s okay. We’re woke.

 

[anonymous]

Our diversity is our strength.

 

[anonymous]

unfortunately another R&D failure for GSK.

You do realize that most drugs in R&D for any Pharma company are not successful, right ?

 

[anonymous]

You do realize that most drugs in R&D for any Pharma company are not successful, right ?

Certainly true at GSK. GSK should just shut R&D down altogether. It's like pouring money down the toilet in the transgender restrooms.

 

[anonymous]

You do realize that most drugs in R&D for any Pharma company are not successful, right ?

You are correct most agents don't make it to patients- GSK's failure rate is much higher than most firms once the trials reach a meaningful point.

 

[anonymous]

Don't you think investors have the data that shows which drug companies have higher success rates of bringing products to market vs other. GSK has one of the lowest success to market rates.

 

[anonymous]

You are correct most agents don't make it to patients- GSK's failure rate is much higher than most firms once the trials reach a meaningful point.

And your data source is ?

 

[anonymous]

Who needs R&D when you have I&D

 

[anonymous]

Certainly true at GSK. GSK should just shut R&D down altogether. It's like pouring money down the toilet in the transgender restrooms.

 

[anonymous]

And your data source is ?

Wall St and the GSK stock price. Suck it.

 

[anonymous]

And your data source is ?

The consistently falling stock price, Duh!!!

 

[anonymous]

GSK fails at everything. Sales, Marketing, Pipeline, Management, Culture, CEO, Stock Price, etc.....Come on man!